Position in QGEN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,178,537
New position
Shares Held
29,434
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in QGEN
reported options exposure · as of Mar 31, 2026CallValue
$8,008
CallShares
200
PutValue
$1,253,252
PutShares
31,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Walleye Trading LLC holds $9,391,151 across 9 Diagnostics & Research names. QGEN ranks #3 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
31,661 | $5,461,522 | |
| 2 | A |
Agilent Technologies, Inc.
|
11,098 | $1,264,950 | |
| 3 | QGEN |
Qiagen N.V.
This page
|
29,434 | $1,178,537 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
3,564 | $607,804 | |
| 5 | RDNT |
RadNet, Inc.
|
8,609 | $481,157 | |
| 6 | WAT |
Waters Corp /De/
|
693 | $206,375 | |
| 7 | DGX |
Quest Diagnostics Inc
|
549 | $107,593 | |
| 8 | NTRA |
Natera, Inc.
|
260 | $51,997 |
All Filings in QGEN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,253,252 | 31,300 | Put | Sole | 2026-05-11 | |
| 2026-03-31 | $8,008 | 200 | Call | Sole | 2026-05-11 | |
| 2026-03-31 | $1,178,537 | 29,434 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||